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Total parenteral nutrition (TPN) leads a loss of epithelial barrier function, decline in epithelial
cell (EC) proliferation, and decreased expression of E-cadherin. As a large portion of intracellular
β-catenin is tightly associated with E-cadherin, we hypothesized that the loss of E-cadherin would
result in a redistribution of intracellular β-catenin, and could be a contributing mechanism for
this TPN-associated loss of EC proliferation. An assessment of small bowel epithelium was
performed in mice given either enteral nutrition (Control) or intravenous nutrition (TPN).
TPN significantly down-regulated E-cadherin and β-catenin expression, and resulted in a
loss of a colocalization of these factors. TPN also up-regulated phosphorylated (p)-β-catenin
(Ser31/33,Thr41) and down-regulated (p)-β-catenin(Ser552) expression. To further address
mechanisms driving this, we observed a significant decrease in the abundance of p-AKT and
p-GSK3β expression, and an associated decline in tcf-4 transcription factors (cyclin D1, c-myc
and Axin2), as well as a loss of EC proliferation by 7 days. To address whether the mechanism
driving these changes was the absence of nutritional factors, glutamine was added to the TPN
solution. This resulted in a partial restoration of β-catenin expression and EC proliferation,
suggesting that an alteration in nutrient delivery may affect many of these changes. Based on
these findings, the loss of EC proliferation with TPN may well be due to a loss of total β-catenin,
as well as a concomintant change in the differential expression of β-catenin phosphorylation
sites, and a reduction in β-catenin mediated tcf-4 transcription. This potential pathway may
well explain many of the findings of mucosal atrophy associated with TPN.
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Total parenteral nutrition (TPN), or the removal of all
enteral nutrition, is vital for the nutritional support of
patients who cannot tolerate enteral nutrients. Despite its
advantages, TPN is associated with a decline in epithelial
cell (EC) proliferation, leading to profound atrophy of
the small intestinal mucosa (Peterson et al. 1996; Yang
et al. 2004). TPN has also been shown to contribute
to a loss of epithelial barrier function (EBF) (Illig et al.
1992; D’Antiga et al. 1999; Yang et al. 2003b; Ziegler et al.
2008). The implications of these changes are significant
in that they may lead to an increase in septic episodes in
a clinical setting, which is associated with a substantially
poorer outcome (Moore et al. 1989, 1992; Frost & Bihari,
1997; Ziegler et al. 2008). Some of the mechanisms which
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account for these TPN-associated mucosal changes have
been studied (Li et al. 1995; Fukatsu et al. 2001; Wildhaber
et al. 2002, 2005; Yang et al. 2002; Yang et al. 2003b).
Intestinal mucosal homeostasis depends on a balance
between cell proliferation and cell death (Foligne et al.
2001; Tang et al. 2006). Previous work by our group has
shown that TPN administration leads to a loss of EBF
including a decreased expression of E-cadherin (Sun et al.
2008). However, it remains to be determined how this
loss of E-cadherin might affect EC physiology in this TPN
model.
Interestingly, a large portion of β-catenin is tightly
associated with the intracellular segment of E-cadherin,
and functions to support and maintain intercellular
adhesion (Huber & Weis, 2001). The intracellular tail of
E-cadherin complexes with both β-catenin and α-catenin
(Itoh et al. 1997; Huber & Weis, 2001), and this complex
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Table 1. Primers used in this experiment
GenBank
Gene accession Forward Reverse Size
Axin2 NM_015732 TGACTCTCCTTCCAGATCCCA TGCCCACACTAGGCTGACA 105
c-Myc NM_023326 AACCGCGACCTGGACTATGA TGGAGAAGCTATCACCGTCGT 238
Cyclin D1 NM_007631 GCGTACCCTGACACCAATCTC CTCCTCTTCGCACTTCTGCTC 183
E-Cadherin NM_009864 CAGCCTTCTTTTCGGAAGACT GGTAGACAGCTCCCTATGACTG 140
β-Catenin NM_007614 ATGGAGCCGGACAGAAAAGC CTTGCCACTCAGGGAAGGA 108
in turns binds to actin, and helps to maintain the
integrity of this adherence protein (Rimm et al. 1995;
Perez-Moreno, 2003). The intracellular distribution of
β-catenin is carefully balanced between this subcellular
membrane population, as well as a second population
which is responsible for Wnt-mediated activation of tcf/lef
nuclear transcription(He et al. 2007). Recent evidence
argues that the signalling and adhesive forms of β-catenin
may tightly interact with each other, and be integrally
dependent (Daugherty & Gottardi, 2007). Investigators
have put forth the contention that the cadherin is a
favourable inhibitor of β-catenin nuclear signalling, not
only because it sequesters β-catenin away from the
nucleus, but also because it can compete directly with tcf
for β-catenin binding (Gottardi Cara & Gumbiner, 2001).
Although this excess of free β-catenin may accelerate cell
proliferation in some states, the loss of E-cadherin may
lead to a ubiquination of the free cytoplasmic β-catenin,
and thus lead to a decline in cell proliferation. The precise
site of β-catenin phosphorylation (p-β-catenin) is an
important mechanism which directs these two pathways.
Phosphorylation sites at serine 33 and 37 and threonine 41
promote binding to the Axin/APC degradation complex
(Hart et al. 1999), whereas phosphorylation at serine
552 has been shown to both release cell–cell contact and
promote entrance into the nucleus for tcf-4 transcription
(Fang et al. 2007). More recently this control via
p-β-catenin has been shown to have relevance to intestinal
EC growth and development of polyposis (He et al. 2007).
Based on our observed loss of E-cadherin with
TPN administration, we hypothesized that the loss of
E-cadherin would lead to a dissociation of E-cadherin
and β-catenin. We further hypothesized that this rapid
increase in intracellular, cytoplasmic β-catenin would then
lead to its phosphorylation and subsequent ubiquination.
Finally, glutamine, a semiessential amino acid, which is
not routinely added to TPN solutions has been observed
to improve intestinal EC proliferation and may well be
mediated via the p-Akt signalling pathway (Seth et al. 2004;
Evans et al. 2005; Larson et al. 2007). We thus further hypo-
thesized that adding glutamine to TPN would reverse the
loss of β-catenin expression, increase p-Akt signalling and
improve EC proliferation. Such a process may well provide
for a mechanism by which EC proliferation is significantly
decreased with TPN administration.
Methods
Animals
C57BL/6J male, specific-pathogen-free mice (8–10 weeks
old; Jackson Laboratory, Bar Harbour, ME, USA) were
maintained under temperature-, humidity- and light-
controlled conditions. Mice were initially fed ad libitum
with standard mouse chow and water, and allowed
to acclimate for 1 week prior to surgery. During the
administration of intravenous solutions, mice were
housed in metabolic cages to prevent coprophagia. The
studies were approved by our University Animal Use
Committee (No. 7703).
Operative procedures and TPN
Cannulation and administration of TPN was identical to
that previously described (Kiristioglu et al. 2002). After
24 h, mice were randomized to a control (enterally fed),
TPN, or TPN plus glutamine (TPN + GLU) group. For the
TPN + GLU group, 2 g glutamine (Sigma-Aldrich) was
added to each 100 ml TPN solution. Nitrogen delivery
was controlled between each group (iso-nitrogenous).
Caloric delivery was also kept isocaloric between groups
(Kiristioglu & Teitelbaum, 1998). All animals were killed
at 7 days using CO2.
Real-time PCR
Muscosal scrapings were placed in TRIzol, homo-
genized, RNA extracted and purified as previously
described (Yang et al. 2003c). Oligomers were designed
using an optimization program Primer Premier
(www.premierbiosoft.com), and sequences of specific
primers are described in Table 1. Real-time PCR (RT-PCR)
was performed using a Rotor-Gene 6000 (Corbett Life
Science, Sydney, Australia) and β-actin was used as an
internal control for normalization. Fold changes of target
genes were calculated using comparative quantification to
β-actin.
Western immunoblotting
Intestinal epithelial cells (EC) were prepared by using
a modification of Grossmann’s technique (Grossmann
C© 2009 The Authors. Journal compilation C© 2009 The Physiological Society
J Physiol 587.3 TPN-associated dissociation of E-cadherin and β-catenin 643
et al. 1998; Schwarz et al. 2007) and these extracts
included crypts and villi Western blotting. Because of
the observed loss of membranous E-cadherin with TPN
administration, using another group of isolated EC
samples, a fractionation of membrane bound and cytosol
proteins was determined by previously described methods
(Basuroy et al. 2005; Suzuki et al. 2007). This yielded
a Triton soluable fraction (non-cytoskeletal fraction)
and a Triton insoluable fraction (cytoskeltetal fraction).
Antibodies (Ab) used included: mouse anti-E-cadherin
Ab (BD Transduction Laboratories; clone IgG2a), mouse
anti-β-catenin Ab (BD Transduction Laboratories, clone
IgG1), rabbit anti-α-catenin Ab (Sigma, St Louis, MO,
USA), rabbit anti-phosphorylated β-catenin Ab (ser31/33,
Thr41, Cell Signaling Technology, Inc., Beverly, MA,
USA), rabbit anti-phosphorylated β-catenin Ab (ser552,
Cell Signaling), rabbit anti-phosphorylated GSK3α/β
(Ser21/9, Cell Signaling), rabbit anti-phosphorylated
Akt1/2/3 (Ser 473, Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA), and mouse anti-PCNA (Cell Signaling).
Secondary antibody was either the corresponding goat
anti-mouse-HRP (Santa Cruz) or goat anti-rabbit anti-
body (Santa Cruz).
Confocal and immunofluorescent microscopy
A 0.5 cm section of fresh jejunum from each mouse
was immediately cut and embedded in an optimum
cutting temperature compound (OCT Tissue-Tek, Sakura
Finetechnical, Tokyo, Japan) by freezing the tissue in
liquid nitrogen. Cryosections of 5 μm thickness were
prepared and fixed with 2% formalin for 15 min
at room temperature (RT). After washing with PBS,
sections were blocked in 10% goat serum for 1 h
and incubated with the primary antibodies (mouse
monoclonal anti-E-Cadherin 1 : 500 and mouse mono-
clonal anti-β-catenin 1 : 250, or rabbit anti-α-catenin
1 : 3000) overnight at 4◦C. After overnight incubation,
the sections were washed again 3 times, corresponding
secondary antibodies were incubated for an additional 1 h
at RT, and slides were mounted with anti-fade permanent
mounting gel (Invitrogen). Fluorescence was analysed by
using an Olympus BX-51 upright light microscope and
Zeiss LSM 510-META laser scanning confocal micro-
scope; images were stacked by using Zeiss proprietary
image software and processed by using Adobe Photoshop
CS2.
Immunohistochemistry
Techniques were similar to that previously described (Yang
et al. 2004), and used anti-p-AKT (1 : 100, Santa Cruz).
Intestinal morphology assessment
Morphology. Intestinal tissue sections and staining were
performed as previously described (Sun et al. 2006).
Five different fields of each specimen were observed
and digital images were recorded with computer-aided
video microscopy. Villus length and crypt depth for each
specimen were measured and analysed using commercially
available quantitative digital image analysis software
(Media Cybernetics Inc., Bethesda, MD, USA).
BrdU Staining. Techniques were as previously described
(Haxhija et al. 2008). An index of the crypt cell
proliferation rate was calculated by the ratio of the number
of BrdU positive crypt cells to the total number of crypt
cells.
Data analysis
Data are expressed as the mean ± standard deviation
(S.D.). Statistical analysis employed Student’s t test for
comparison of two means, and a one-way ANOVA for
comparison of multiple groups (with Bonferoni’s post hoc
analysis to assess statistical differences between groups).
The chi-square test was used for categorical data (Prism
software; GraphPad Software, Inc., San Diego, CA, USA).
Statistical significance was defined as P < 0.05.
Results
E-Cadherin, α-catenin and β-catenin expression
are decreased with TPN administration
TPN administration resulted in significantly decreased
E-cadherin and β-catenin expression in jejunal
epithelium. Compared with controls, there was a
7-fold decline in mRNA expression (7.17 ± 1.28 versus
1.03 ± 0.12, P < 0.01) in E-cadherin and an 8-fold decline
(6.01 ± 0.94 versus 0.77 ± 0.08, P < 0.01) in β-catenin at
7 days (Fig. 1A and B). To confirm these observations,
Western immunoblots were performed. Similar to the
real-time PCR results, a 4-fold decline in protein
expression (0.33 ± 0.19 versus 0.078 ± 0.016, P < 0.01)
for E-cadherin was observed. β-Catenin was almost
non-detectable in our TPN group (Fig. 1C–E).
To help account for the loss of both E-cadherin and
β-catenin, we next assessed the intracellular distribution
of E-cadherin as well as α-catenin, as α-catenin is
known to be tightly linked to both E-cadherin and
β-catenin. The presence of E-cadherin and α-catenin
was examined in both the cytoskeletal-associated fraction
and the non-cytoskeletal fraction by assessing the
amount measured in the Triton soluble (non-cytoskeletal)
and Triton insoluble (cytoskeletal fraction) fractions,
respectively. This was not done for β-catenin as it was
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weakly expressed following TPN administration. The
expression of both E-cadherin andα-catenin was markedly
decreased in the insoluble fraction and increased in
the soluble fraction after TPN administration at 7 days
(Fig. 2). This suggested a dissociation of these molecules
from the cell membrane and actin cytoskeleton. We next
investigated the intracellular distribution of β-catenin.
Figure 1. mRNA and protein expression of E-cadherin and
β-catenin from intestinal EC measured by real-time PCR (A and
B) and western immunoblots (C–E)
A and B, results are expressed as the mean fold increase in target
mRNA relative to β-actin mRNA. Compared with controls, mRNA
expression of E-cadherin (A) and β-catenin (B) was significantly
decreased after 7 days of TPN administration. C, representative gels
for both E-cadherin and β-catenin. D and E, results of E-cadherin and
β-catenin protein expression are shown. Both factors decreased
significantly with TPN administration compared with controls. Note
that glutamine administration partially prevented the TPN-associated
decline in β-catenin expression; however, glutamine did not affect
E-cadherin expression at either 3 or 7 days. ∗P < 0.01, ∗∗P < 0.001,
#P < 0.05. Abbreviations: TPN, total parenteral nutrition; n = 5–6 for
each group; ∗∗P < 0.001.
Expression of E-cadherin and β-catenin decreased
in both villi and crypts following TPN
The pattern of E-cadherin and β-catenin expression was
analysed along the crypt–villus axis to further address
the loss of these factors with TPN administration using
immunofluorescence staining. The fluorescence intensity
for E-cadherin and β-catenin along the villus portion
of the jejunum was consistently weaker in the TPN
group than in controls (Fig. 3A and B). Compared to
the control group, TPN administration also resulted in a
redistribution of E-cadherin and β-catenin. Interestingly,
we noted an internalization of E-cadherin from the cell
membrane into the cytoplasm of TPN mice. Further,
the appearance of a sharp mesh like grid, and a tight
colocalization of these two factors, observed in controls,
was markedly diminished with TPN.
Figure 1. Continued
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A similar pattern was observed in the crypt region of
the small bowel (Fig. 4A). Within the crypts there was
a significant decline in both E-cadherin and β-catenin
expression with TPN. This loss of β-catenin expression
was particularly prominent within EC nuclei (Fig. 4B);




β-catenin(Ser31/33,Thr41) was up-regulated with TPN
Site specific phosphorylation of β-catenin is the major
mechanism by which this factor is directed to either
ubiquination or promotes nuclear transcription of tcf-4.
β-Catenin phosphorylated at serine 31 and 33, as well
as threonine 41 results in the rapid binding of the
Axin/APC complex and ubiquination (Daugherty &
Gottardi, 2007), whereas, β-catenin phosphorylated at
serine 552 promotes nuclear transcription (Taurin et al.
2006). EC β-catenin phosphorylation was measured
with immunoblots. Compared with controls, TPN
administration led to an increased phosphorylation
of β-catenin on sites Ser33/37/Thr41 (Fig. 5A). This
represented a greater than 2-fold increase in protein
expression at 7 days (0.66 ± 0.12 versus 0.26 ± 0.07, TPN
versus Control, P < 0.01) (Fig. 5B). Additionally, a nearly
10-fold down-regulation of phosphorylation of β-catenin
at Ser552 was noted after 7 days of TPN (0.09 ± 0.05 versus
0.70 ± 0.31, TPN versus Control, P < 0.05) (Fig. 5C). Note
that we were able to detect these low levels of protein
expression by using higher amounts of protein for these
immunoblots (100 μg versus 40 μg in the results shown in
Fig. 1).
Phosphorylated Akt and phosphorylated GSK3β were
down-regulated with TPN administration
The upstream factors which are known to modulate
the phosphorylation of β-catenin were next examined.
This included phosphorylated Akt (p-Akt) and p-GSK3β.
Almost no p-Akt was detected after 3 days of TPN
administration, and this remained significantly lower than
enterally fed controls (a 6-fold decline in the protein
expression) at 7 days (0.11 ± 0.04 versus 0.62 ± 0.16,
P < 0.01) (Fig. 6A and B). For p-GSK3β a 3-fold decline
(Fig. 7) was detected in the TPN administration group
both at 3 days (0.66 ± 0.12 versus 0.26 ± 0.07, control
versus TPN, P < 0.01) and at 7 days (0.66 ± 0.12 versus
0.20 ± 0.09, control versus TPN, P < 0.01).
In order to detect the location of these changes
in phosphorylation along the crypt–villus axis, p-Akt
immunohistochemistry was performed. This showed that
in the control group p-Akt positive cells were almost
exclusively located at the base of the crypt; however, there
were virtually no p-Akt positive cells found after 3 days of
TPN (Fig. 6C).
Down-stream tcf/lef transcription factors
As a marked loss of β-catenin (nuclear and cytoplasmic)
was detected in TPN mice, it was next determined if
this resulted in a loss of tcf-4 transcriptional activation.
c-myc, cyclin D1 and Axin2 are three major regulators
of the progression of cells into the proliferative stage of
the cell cycle (Sherr, 1996; Shtutman et al. 1999; He et al.
Figure 2. Expression of E-cadherin and α-catenin redistribution
with the administration of TPN
A, representative gels for the Triton insoluble and Triton soluble
fractions of E-cadherin and α-catenin protein expression. B and C,
immunoblot expression results for E-cadherin (B) and α-catenin (C)
relative to the expression of β-actin. Note that for both factors there
was a decrease in the Triton insoluble fraction and an increased
expression of the Triton soluble fraction. This suggests that both
adherens junctional proteins moved from the cytoskeletal to the
non-cytoskeletal regions of the epithelial cell. n = 6 per group;
∗P < 0.01.
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2007); and these factors also represent classic down-stream
activation factors following β-catenin activation of tcf-4
transcription. Compared with controls after 7 days of
TPN, there was a nearly 10-fold decrease in mRNA
expression (0.026 ± 0.009 versus 0.002 ± 0.004, P < 0.01)
for c-myc, a 7-fold decrease for cyclin D1 (29.3 ± 5.58
versus 4.86 ± 2.55, P < 0.01) and a 5-fold for Axin2
(33.7 ± 6.82 versus 7.30 ± 3.05, P < 0.01) (Fig. 8). For
c-myc and cyclin D1, these declines were noted as earlier
as 3 days of TPN (Fig. 8).
Figure 3. Representative immunofluoresence staining for E-cadherin and β-catenin in the villus region
A, note that there was a marked decline in intensity for both E-cadherin and β-catenin with TPN administration
along the villi. B, at higher magnification, compared to controls, TPN administration led to a marked loss of
β-catenin in the EC cytoplasm as well as a nearly total loss along the cellular membrane. Additionally, TPN led
to a redistribution of E-cadherin, with internalization from cell membrane into cytoplasm (note the asterick (∗),
marks where there is internalization for the TPN group, and that this is distinctly absent in the control group).
E-Cadherin and β-catenin expression had the appearance of a sharp mesh-like grid in controls (marked by arrows),
and this was absent in TPN mice (a versus d). The strong colocalization of β-catenin to E-cadherin (c) in controls
also diminished with TPN (d).
Intestinal epithelial cell proliferation decreased
with TPN
As the decreased expression of cyclin D1, c-myc and
Axin2 are representative of critical tcf transcription factors
for cell proliferation, we next examined changes in EC
growth parameters in TPN mice. Villus length and crypt
depth in the TPN groups were significantly reduced
as compared to the controls (P < 0.01). Histological
examination demonstrated a 22% decline in jejunal villus
height (308.4 ± 65.2 versus 397.0 ± 49.5 μm), and a 37%
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decline in crypt depth (76.1 ± 7.4 versus 121.4 ± 27.2 μm)
in TPN mice compared with controls (Table 2).
PCNA is synthesized in the S phase of the cell cycle
and was used as a marker for proliferating cells. Western
blot results showed a significantly decreased expression of
PCNA with TPN administration at 7 days (Fig. 9A and B).
Figure 4
A, representative immunofluoresence staining for E-cadherin and β-catenin in the crypt region. B, a detailed
imaging of β-catenin in the crypt cells of the small intestine is shown. Note that compared to controls (a and c),
TPN administration (b and d) led to a decline in β-catenin expression in crypt cells (shown by white arrows), and a
marked loss of cytosolic and nuclear β-catenin expression was detected in the TPN mice.
Intestinal EC proliferation rates were also determined
by BrdU staining, and were found to be significantly
decreased (P < 0.01) compared to controls (13.5 ± 2.4%
versus 24.4 ± 4.2%, TPN and controls, respectively;
Fig. 9C).
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Figure 5. TPN administration altered β-catenin phosphorylation
at different sites in the molecule
A, representative bands for phosphorylated β-catenin expression in
ECs. B, results of Western immunoblotting are expressed as the ratio
of the protein expression to β-actin protein phosphorylated at
Ser31/33,Thr41 relative to β-actin expression. C, results of Western
immunoblotting are expressed as the ratio of the protein expression to
β-actin protein phosphorylated at Ser552 relative to β-actin
expression. Note that phosphorylated β-catenin at Ser31/33,Thr41
increased with TPN at 3 and 7 days, and that glutamine administration
prevented this change. Conversely, β-catenin phosphorylated at
Ser552 was down-regulated with TPN, and this decline reached
significance at 7 days. At both days 3 and 7 of TPN with glutamine
administration no significant change in p-β-catenin expression at
Ser552 was noted. Note, because of the markedly diminished amount
of β-catenin expression in TPN mice, for these experiments 100 μg of
protein was used (versus 40 μg in previous studies). Abbreviations:
TPN + G, TPN supplemented with glutamine. n = 4–6 per group;
∗P < 0.01, ∗∗P < 0.001.
Glutamine administration increased EC proliferation
and β-catenin expression
To further examine what factors might contribute to the
TPN-associated loss of EC proliferation and the decline in
E-cadherin and catenin expression, it was next investigated
if a potentially important nutritional factor might be
missing from the standard parenteral nutrition solution. It
has been previously documented that glutamine, an amino
acid not routinely added to TPN solutions in a clinical
setting, may be a critical factor for adequate cell growth
and survival (Yang et al. 2000; Zarzaur et al. 2002b; Evans
et al. 2005; Larson et al. 2007). Further, supplementation of
glutamine to intestinal EC has been shown to be effective in
restoring tight junctions after acetaldehyde induced injury,
and the mechanism appears to be via restoration of the
distribution of E-cadherin, catenins and other junctional
molecules(Basuroy et al. 2005). We therefore utilized a
separate group of TPN mice, which were supplemented
Figure 6. Phosphorylated-Akt (p-AKT) activity decreased with
TPN administration
A, shown are representative bands for p-Akt and total Akt expression
for TPN and control groups. B, the ratio of p-AKT to total AKT
decreased with TPN administration, at 3 and 7 days. Glutamine
administration partially reversed this decline. C, p-AKT
immunohistochemical expression showed similar results. In control
mice, large numbers of positive staining cells (shown by yellow arrows)
were found at the base of the crypt (a upper panel). After 3 days of
TPN administration (b middle panel), p-AKT positive cells were
markedly decreased in numbers. The lower panel (c) shows p-AKT
expression in the TPN + glutamine group. Note that the loss of p-AKT
expression was partly prevented with the addition of glutamine.
n = 4–6 per group; ∗P < 0.01 ∗∗P < 0.001.
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with glutamine. We hypothesized that the addition of this
amino acid would reverse our observed changes in p-Akt
activity, and subsequently improve EC proliferation.
TPN supplemented with glutamine prevented the
observed TPN-associated decline in PCNA expression,
and resulted in an increase in intestinal EC proliferation
rates with TPN (Fig. 9). To investigate the mechanisms
driving this increase in EC proliferation, we then looked at
the Akt/GSK3 cascade. Glutamine supplementation led to
an associated increase in p-Akt expression (Fig. 6), and this
Figure 6. Continued
increase was noted as early as 3 days after the initiation of
TPN, a time at which there was almost no detectable p-Akt
in the un-supplemented TPN (standard) group. Immuno-
histochemical staining of p-Akt (Fig. 6) demonstrated a
strong presence of p-Akt with glutamine administration
in the crypt region.
Additionally, the significant decline in p-GSK3β
observed with TPN administration was completely pre-
vented with glutamine supplementation (Fig. 7). To
examine the effect of this sustained p-GSK3β and
p-Akt expression, we next examined the expression of
p-β-catenin. As noted previously, a significant increase in
the p-β-catenin on Ser31/31,Thr41 was found with TPN
administration. With glutamine supplementation this
increase was partially prevented at both 3 and 7 days after
the initiation of TPN (Fig. 5). Glutamine administration,
however, did not affect the loss of p-β-catenin expression at
Ser552 in the TPN group (Fig. 5). Based on these findings,
we next examined the effect of glutamine expression on
Figure 7. Expression of p-GSK3β was down-regulated with TPN
administration
A, representative bands of p-GSK3β and total GSK3β are shown for
each study group, as well as β-actin for normalization. Note that
GSK3β is shown as the lower of the two bands; and GSK3α is the
upper band. B, results of Western immunoblotting as expressed as the
ratio of the protein expression of p-GSK3β to total GSK3β. Note the
decline in p-GSK3β with TPN administration, and this down-regulation
was reversed with glutamine. #P < 0.05, n = 4–6 per group.
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the presence and stability of unphosphorylated β-catenin.
Interestingly, TPN supplemented with glutamine resulted
in a partial recovery of β-catenin expression, and this
recovery was seen at both days 3 and 7 after TPN
Figure 8. TPN administration led to a decreased expression of
several down-stream tcf-4 transcription genes
Cyclin D1 (A), c-myc (B) and Axin2 (C) expression significantly
decreased after 7 days of TPN. For c-myc and cyclin D1, this decline
was noted as early as 3 days after TPN administration. Glutamine
supplemented TPN prevented the observed decline for cyclin D1 and
Axin2 expression. ∗P < 0.01, ∗∗P < 0.001, #P < 0.05; n = 4–6 per
group.
Table 2. Morphologic changes in the jejunal crypts and villi
Groups Villus length (μm) Crypt depth (μm)
Control 397.4 ± 49.5 121.4 ± 27.2
TPN 308.4 ± 65.2∗ 76.1 ± 7.4∗
∗Compared with control group: P < 0.01.
administration. However, glutamine had no effect on
the decline in E-cadherin expression at either time point
(Fig. 1).
This partial prevention of β-catenin loss led to a
partial prevention in the decreased expression of the tcf-4
transcription factors (c-myc, Axin2 and cyclin D1) at
both day 3 and to a lesser degree at day 7 after TPN
administration (Fig. 8). This suggests that the partial
prevention in the decline of tcf-4 transcription was a
mechanism responsible for sustaining EC proliferation
compared to the standard TPN group.
Discussion
Our study demonstrated that TPN in a mouse model led
to several significant changes in jejunal epithelial cells,
including a loss of E-cadherin and β-catenin, and this
was associated with a dramatic loss of EC proliferation.
β-Catenin is a key cytoplasmic protein that functions in
two different cellular processes: intercellular adhesion and
Wnt-mediated transcriptional activation (Daugherty &
Gottardi, 2007). The vast majority of β-catenin resides
in the cytoskeletal fraction, and binds to E-cadherin and
α-catenin. This trimolecular complex of the adherens
junctional proteins, β-catenin and α-catenin (Gates &
Peifer, 2005) allows for it to maintain its association
with the actin cytoskeleton and contribute to cell–cell
adhesion(Rimm et al. 1995). The other essential role
for β-catenin is to help mediate EC proliferation via
transcription of T-cell factor-4 (tcf-4) (Tutter et al.
2001; Batlle et al. 2002; Gregorieff et al. 2005). Each of
these actions derive from a common pool of β-catenin
(Gottardi Cara & Gumbiner, 2001). Although the loss
of β-catenin–E-cadherin association in our TPN model
could lead to an increase in β-catenin-mediated tcf-4
signalling, in our TPN model we observed the converse.
Regulation of β-catenin has been well-demonstrated to
be modulated by its degradation via its association
with Axin1, CK1, GSK-3β and APC (abbreviated as the
Axin1/APC in this paper) complex. The binding to this
Axin1/APC complex results in the prompt ubiquination
ofβ-catenin, and relies onβ-catenin being phosphorylated
at Ser31/33,Thr41 (Liu et al. 2002; Gottardi & Gumbiner,
2004; Daugherty & Gottardi, 2007), whereas the activation
of Wnt signalling leads to the intracellular accumulation of
β-catenin, which subsequently translocates to the nucleus
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to activate the expression of target genes, leading to cell
proliferation (Akiyama, 2000; Kikuchi, 2000; Peifer &
Polakis, 2000; van Noort & Clevers, 2002; Kikuchi et al.
2006). In our study, TPN administration led to a loss
of p-β-catenin at Ser552, a key site of phosphorylation
which promotes tcf-4 transcription (Taurin et al. 2006;
He et al. 2007), and an increase in p-β-catenin at
Ser31/33,Thr41. This corresponded to our observation of
decreased expression of tcf-4 transcription factors Axin2,
cyclin D1 and c-myc, and a loss of EC proliferation, all of
which are critical for cell proliferation (Sherr, 1996; Miller
et al. 1999; Shtutman et al. 1999; Takayama et al. 2006).
These findings closely fit with the observation of a marked
decline in EC proliferation with TPN administration (Yang
et al. 2003a, 2004). The observed loss of α-catenin in
our study may also have significant implications, as it has
been shown that α-catenin can also play a significant role
in modulating EC proliferative signalling (Scott & Yap,
2006).
Akt and GSK3β play an important role in
the modulation of this Axin1/APC complex. In
non-proliferative states, the activity GSK3β is inhibited by
the factor existing in a phosphorylated state (Daugherty
& Gottardi, 2007). This phosphorylation is modulated
by PI3 kinase and Akt signalling (Sheng et al. 2003). In
our current study, p-Akt was significantly down-regulated
with TPN administration. Such a loss of p-Akt closely
corroborates the findings of Sheng et al. where the
administration of a diet consisting of glucose, electro-
lytes and water resulted in a loss of p-Akt expression,
and a return of p-Akt expression rapidly occurred with
the administration of a solid diet (Sheng et al. 2003).
Our observed loss of p-Akt could well be the mechanism
contributing to the observed down-regulation in p-GSK3β
and the increase in p-β-catenin at Ser31/33,Thr41, as
well as the up-regulation of p-β-catenin at Ser552.
These actions would clearly account for a subsequent
ubiquination of β-catenin. Alternatively, Akt can activate
β-catenin–tcf-4/lef-1 transcriptional activity by a direct
phosphorylation of β-catenin and this action enhances
nuclear accumulation of β-catenin (Fang et al. 2007).
In this study, we used PCNA and incorporation of
BrdU as markers of EC proliferation. The results showed
the expression of PCNA was lost after 7 days of TPN
administration, and was consistent with the marked
decline in BrdU uptake at this same time point.
A critical question which will need to be investigated
with future experiments will be whether this cascade was
initiated by the loss of E-cadherin expression, or if the
administration of TPN led to changes in the Akt/GSK3
cascade, both of which could lead to a loss of β-catenin
and could also affect E-cadherin expression. Our findings
of a partial reversal of many of these changes with the
addition of glutamine to the TPN solution were quite
intriguing. Glutamine is an amino acid which has been
demonstrated to affect cellular proliferation in vitro and
in vivo (Gu et al. 2001), and glutamine is an important
factor for intestinal epithelial (Ziegler et al. 2000; Evans
et al. 2005) and lymphoid functionality (DeWitt et al. 1999;
Zarzaur et al. 2002a). This increase in EC proliferation was
also seen in this present study with glutamine. One of the
mechanisms by which glutamine mediates such actions
is its ability to alter Akt expression (Larson et al. 2007).
Glutamine also prevented the loss of p-Akt expression
with TPN administration. In a recent study, glutamine
Figure 9. Proliferating cell nuclear antigen (PCNA) expression
A, representative bands of PCNA and β-actin, which was used for
normalization. B, results of Western immunoblotting as expressed as
the ratio of the PCNA to β-actin. A slight decline was noted at 3 days,
and a this decline became significant after 7 days of TPN
administration. Glutamine supplemented TPN prevented this decline at
3 days, and partially prevented the decline at day 7. C, crypt cell
proliferation is shown as detected by the counting of BrdU positive
staining. TPN again led to a significant decline in proliferation
compared to control mice; and glutamine supplemented TPN (T + G)
prevented this decline in proliferation rates. Results for BrdU staining
are shown for day 7. #P < 0.05, ∗∗P < 0.001; n = 4–6 per group.
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removal for 24 h in rat intestinal epithelial (RIE)-1 cells
resulted in an increase in p-Akt expression, and the
addition of glutamine resulted in a marked loss of p-Akt
(Larson et al. 2007). Although different from our own
findings, the authors attributed this decreased expression
of p-Akt as a protective effect against the development
of EC apoptosis. It also may well be that this finding is a
relatively specific finding to this cell line. Although changes
in protein synthesis with TPN may have led to some of
these changes, this appears less likely. Both groups received
similar amounts of nitrogen and calories (Sun et al. 2006),
and the fact that protein immunoblots were controlled by
the amount of β-actin also makes this less likely.
TPN supplemented with glutamine led to an
up-regulation of β-catenin expression. As well, glutamine
prevented the increased expression of p-β-catenin at
Ser31/33/Thr41; however, it was also intriguing that
glutamine did not change the phosphorylation state of
β-catenin at Ser552. This was somewhat surprising in that
glutamine has been shown to promote other signalling
pathways such as activation of extracellular signal-related
kinase (ERK) or protein kinase D (PKD), both of which
have been shown to be up-regulated in vitro in EC exposed
to glutamine (Larson et al. 2007). Because Wnt signalling
can affect the phosphorylation status of β-catenin, in the
future it will be interesting to investigate the influence of
glutamine on Wnt expression (van Noort et al. 2002).
Glutamine also did not have a significant effect
on E-cadherin expression. Glutamine has been
previously shown to protect acetaldehyde disrupted
adherens junctions – most likely by promoting EGF
activity (Seth et al. 2004). Additional future work
examining the effect of TPN on EGF signalling will also be
needed. Further, the PI3K/p-Akt system has been closely
associated with sustaining the adherens junction (Laprise
et al. 2002). Thus, it is possible that other factors, which
have been shown to alter junctional protein expression and
prevent normal EC proliferation, such as an up-regulation
of pro-inflammatory cytokines, including interferon γ and
tumour necrosis factor α in our TPN model, may play a
more dominant role, despite the addition of glutamine
(Bruewer et al. 2003; Ivanov et al. 2004; Clayburgh et al.
2005; Sipos et al. 2005).
In conclusion, our study reported the loss of
β-catenin and E-cadherin in the small bowel of mice
given TPN. TPN also led to a decline in p-Akt and
p-GSK3β; each of these actions potentially accounted
for a differential phosphorylation of β-catenin (increased
β-Ser31/33,Thr41, and decreased Ser552), with resultant
ubiquination. This suggests a potential mechanism for
the loss of cytosolic β-catenin as observed in this study.
The implications of this loss are seen by a loss of tcf-4
transcriptional activation, and decreased EC proliferation.
The prevention of several of these changes with glutamine
supports a potential clinical application of this amino
acid. This potential pathway may well explain many of
the findings of mucosal atrophy associated with TPN, and
may suggest modalities to avoid TPN-associated intestine
atrophy.
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